{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:23:27Z","timestamp":1787747007098,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA271410"],"award-info":[{"award-number":["U01CA271410"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS064571"],"award-info":[{"award-number":["NS064571"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multiple sclerosis lesions are dominated by clonally expanded CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells within an IFN\u03b3-rich inflammatory microenvironment and neurons may be targets of these effector cells. However, the peptide antigens that CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells recognize on neurons are largely undefined. Neurons constitutively express low levels of HLA class I, and whether inflamed human neurons are competent to present a class I ligandome, what that ligandome contains, and whether presentation has functional consequences for autoreactive CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells remain open questions. Here we combine human iPSC-derived neural aggregates (HNAs), HLA class I immunoprecipitation coupled to LC-MS\/MS immunopeptidomics, and microfluidic co-culture assays to map IFN\u03b3-induced HLA class I presentation by neurons and to test antigen-specific cytotoxicity. IFN\u03b3 stimulation induced HLA class I upregulation in HNAs and enabled recovery of a canonical 8-12-mer class I ligandome enriched for 9-mers. Neuron-restricted expression of a synapsin-driven polyepitope cassette yielded presentation of defined exogenous 9-mer peptides on donor HLA class I molecules and, in the presence of IFN\u03b3, elicited activation of autologous antigen-specific CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and antigen-dependent neurite injury. Across four donors, comparative immunopeptidomics identified IFN\u03b3-associated neural peptide repertoires that were distinct from those of matched fibroblasts and enriched for predicted HLA-B binding peptides. \u03b22-microglobulin deletion ablated peptide recovery, and neuron-restricted reconstitution enabled identification of candidate neuron-derived peptides, including recurrent neurofilament light (NEFL)-derived peptides detected across donors. Together, these findings establish a human iPSC-derived platform for studying inflammatory neuronal HLA class I antigen presentation and antigen-dependent CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell engagement.\n                  <\/jats:p>","DOI":"10.1186\/s12974-026-03915-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:16:58Z","timestamp":1781662618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human iPSC-derived neurons stimulated with IFN\u03b3 present HLA class I-restricted antigens to cytotoxic CD8+ T cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Benjamin DS","family":"Clarkson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L","family":"Overlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramila Barun","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K","family":"Mangalaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remya","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-8739","authenticated-orcid":false,"given":"Charles L","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuron.2024.12.006","volume":"113","author":"Y Segal","year":"2025","unstructured":"Segal Y, Soltys J, Clarkson BDS, Howe CL, Irani SR, Pittock SJ. Toward curing neurological autoimmune disorders: Biomarkers, immunological mechanisms, and therapeutic targets. Neuron. 2025;113:345\u201379.","journal-title":"Neuron"},{"key":"3915_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, et al. Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol. 2018;83:210\u201322.","journal-title":"Ann Neurol"},{"key":"3915_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ana.24241","volume":"76","author":"R Schlaeger","year":"2014","unstructured":"Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, et al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014;76:568\u201380.","journal-title":"Ann Neurol"},{"key":"3915_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.192.3.393","volume":"192","author":"H Babbe","year":"2000","unstructured":"Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med. 2000;192:393\u2013404.","journal-title":"J Exp Med"},{"key":"3915_CR5","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1073\/pnas.0308689100","volume":"101","author":"C Skulina","year":"2004","unstructured":"Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N. Multiple sclerosis: brain-infiltrating CD8\u2009+\u2009T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A. 2004;101:2428\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3915_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","volume":"25","author":"H Neumann","year":"2002","unstructured":"Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002;25:313\u20139.","journal-title":"Trends Neurosci"},{"key":"3915_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Bruck W, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015;78:710\u201321.","journal-title":"Ann Neurol"},{"key":"3915_CR8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1177\/1352458520974357","volume":"27","author":"S Klistorner","year":"2021","unstructured":"Klistorner S, Barnett MH, Yiannikas C, Barton J, Parratt J, You Y, Graham SL, Klistorner A. Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients. Mult Scler. 2021;27:1533\u201342.","journal-title":"Mult Scler"},{"key":"3915_CR9","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1038\/s41467-025-62405-6","volume":"16","author":"E Terrabuio","year":"2025","unstructured":"Terrabuio E, Pietronigro EC, Bani A, Della Bianca V, Laudanna C, Rossi B, Finotti G, Santos-Lima B, Zenaro E, Turano E, et al. CD103(-)CD8(+) T cells promote neurotoxic inflammation in Alzheimer\u2019s disease via granzyme K-PAR-1 signaling. Nat Commun. 2025;16:8372.","journal-title":"Nat Commun"},{"key":"3915_CR10","doi-asserted-by":"publisher","first-page":"fcae428","DOI":"10.1093\/braincomms\/fcae428","volume":"6","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Ban JJ, Kang J, Im HR, Ko SH, Sung JJ, Park SH, Park JE, Choi SJ. Single-cell analysis reveals expanded CD8(+) GZMK (high) T cells in CSF and shared peripheral clones in sporadic amyotrophic lateral sclerosis. Brain Commun. 2024;6:fcae428.","journal-title":"Brain Commun"},{"key":"3915_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","volume":"24","author":"W Su","year":"2023","unstructured":"Su W, Saravia J, Risch I, Rankin S, Guy C, Chapman NM, Shi H, Sun Y, Kc A, Li W, et al. CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat Immunol. 2023;24:1735\u201347.","journal-title":"Nat Immunol"},{"key":"3915_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615:668\u201377.","journal-title":"Nature"},{"key":"3915_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-022-04844-5","volume":"606","author":"L Campisi","year":"2022","unstructured":"Campisi L, Chizari S, Ho JSY, Gromova A, Arnold FJ, Mosca L, Mei X, Fstkchyan Y, Torre D, Beharry C, et al. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature. 2022;606:945\u201352.","journal-title":"Nature"},{"key":"3915_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404.","journal-title":"Nature"},{"key":"3915_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/acn3.516","volume":"5","author":"BDS Clarkson","year":"2018","unstructured":"Clarkson BDS, Patel MS, LaFrance-Corey RG, Howe CL. Retrograde interferon-gamma signaling induces major histocompatibility class I expression in human-induced pluripotent stem cell-derived neurons. Ann Clin Transl Neurol. 2018;5:172\u201385.","journal-title":"Ann Clin Transl Neurol"},{"key":"3915_CR16","doi-asserted-by":"crossref","unstructured":"Clarkson BD, Grund EM, Standiford MM, Mirchia K, Westphal MS, Muschler LS, Howe CL. CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis. J Clin Invest. 2023;133(21):e162788.","DOI":"10.1172\/JCI162788"},{"key":"3915_CR17","doi-asserted-by":"publisher","first-page":"103768","DOI":"10.1016\/j.isci.2022.103768","volume":"25","author":"P Kubiniok","year":"2022","unstructured":"Kubiniok P, Marcu A, Bichmann L, Kuchenbecker L, Schuster H, Hamelin DJ, Duquette JD, Kovalchik KA, Wessling L, Kohlbacher O, et al. Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. iScience. 2022;25:103768.","journal-title":"iScience"},{"key":"3915_CR18","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1073\/pnas.90.24.11568","volume":"90","author":"J Girdlestone","year":"1993","unstructured":"Girdlestone J, Isamat M, Gewert D, Milstein C. Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proc Natl Acad Sci U S A. 1993;90:11568\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3915_CR19","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","volume":"2","author":"B Brynedal","year":"2007","unstructured":"Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE. 2007;2:e664.","journal-title":"PLoS ONE"},{"key":"3915_CR20","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","volume":"93","author":"WT Wissemann","year":"2013","unstructured":"Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H. Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet. 2013;93:984\u201393.","journal-title":"Am J Hum Genet"},{"key":"3915_CR21","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","volume":"191","author":"S Paul","year":"2013","unstructured":"Paul S, Weiskopf D, Angelo MA, Sidney J, Peters B, Sette A. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol. 2013;191:5831\u20139.","journal-title":"J Immunol"},{"key":"3915_CR22","doi-asserted-by":"publisher","first-page":"e0136417","DOI":"10.1371\/journal.pone.0136417","volume":"10","author":"IM Schellens","year":"2015","unstructured":"Schellens IM, Hoof I, Meiring HD, Spijkers SN, Poelen MC, van Gaans-van den Brink JA, van der Poel K, Costa AI, van Els CA, van Baarle D, Kesmir C. Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome. PLoS ONE. 2015;10:e0136417.","journal-title":"PLoS ONE"},{"key":"3915_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s42485-021-00066-x","volume":"12","author":"KK Mangalaparthi","year":"2021","unstructured":"Mangalaparthi KK, Madugundu AK, Ryan ZC, Garapati K, Peterson JA, Dey G, Prakash A, Pandey A. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I. J Proteins Proteom. 2021;12:151\u201360.","journal-title":"J Proteins Proteom"},{"key":"3915_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","volume":"40","author":"C Chong","year":"2022","unstructured":"Chong C, Coukos G, Bassani-Sternberg M. Identification of tumor antigens with immunopeptidomics. Nat Biotechnol. 2022;40:175\u201388.","journal-title":"Nat Biotechnol"},{"key":"3915_CR25","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg M, Braunlein E, Klar R, Engleitner T, Sinitcyn P, Audehm S, Straub M, Weber J, Slotta-Huspenina J, Specht K, et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat Commun. 2016;7:13404.","journal-title":"Nat Commun"},{"key":"3915_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","volume":"15","author":"EA Bach","year":"1997","unstructured":"Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997;15:563\u201391.","journal-title":"Annu Rev Immunol"},{"key":"3915_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41586-019-0988-7","volume":"567","author":"JL Mendoza","year":"2019","unstructured":"Mendoza JL, Escalante NK, Jude KM, Sotolongo Bellon J, Su L, Horton TM, Tsutsumi N, Berardinelli SJ, Haltiwanger RS, Piehler J, et al. Structure of the IFNgamma receptor complex guides design of biased agonists. Nature. 2019;567:56\u201360.","journal-title":"Nature"},{"key":"3915_CR28","doi-asserted-by":"publisher","first-page":"1616113","DOI":"10.3389\/fimmu.2025.1616113","volume":"16","author":"JB Nilsson","year":"2025","unstructured":"Nilsson JB, Greenbaum J, Peters B, Nielsen M. NetMHCpan-4.2: improved prediction of CD8\u2009+\u2009epitopes by use of transfer learning and structural features. Front Immunol. 2025;16:1616113.","journal-title":"Front Immunol"},{"key":"3915_CR29","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48:W449\u201354.","journal-title":"Nucleic Acids Res"},{"key":"3915_CR30","doi-asserted-by":"publisher","first-page":"103149","DOI":"10.1016\/j.conb.2025.103149","volume":"96","author":"J Nulman","year":"2025","unstructured":"Nulman J, Ulrich JD, Holtzman DM. Context matters: Conflicting roles of interferon-gamma signaling in CNS diseases. Curr Opin Neurobiol. 2025;96:103149.","journal-title":"Curr Opin Neurobiol"},{"key":"3915_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2023.04.008","volume":"111","author":"BD Hobson","year":"2023","unstructured":"Hobson BD, Stanley AT, De Los Santos MB, Culbertson B, Mosharov EV, Sims PA, Sulzer D. Conserved and cell type-specific transcriptional responses to IFN-gamma in the ventral midbrain. Brain Behav Immun. 2023;111:277\u201391.","journal-title":"Brain Behav Immun"},{"key":"3915_CR32","doi-asserted-by":"publisher","first-page":"eaay9506","DOI":"10.1126\/sciadv.aay9506","volume":"6","author":"K Warre-Cornish","year":"2020","unstructured":"Warre-Cornish K, Perfect L, Nagy R, Duarte RRR, Reid MJ, Raval P, Mueller A, Evans AL, Couch A, Ghevaert C, et al. Interferon-gamma signaling in human iPSC-derived neurons recapitulates neurodevelopmental disorder phenotypes. Sci Adv. 2020;6:eaay9506.","journal-title":"Sci Adv"},{"key":"3915_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41467-025-55908-9","volume":"16","author":"A Carre","year":"2025","unstructured":"Carre A, Samassa F, Zhou Z, Perez-Hernandez J, Lekka C, Manganaro A, Oshima M, Liao H, Parker R, Nicastri A, et al. Interferon-alpha promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic beta-cells. Nat Commun. 2025;16:765.","journal-title":"Nat Commun"},{"key":"3915_CR34","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.4049\/jimmunol.1301670","volume":"192","author":"SM Rizvi","year":"2014","unstructured":"Rizvi SM, Salam N, Geng J, Qi Y, Bream JH, Duggal P, Hussain SK, Martinson J, Wolinsky SM, Carrington M, Raghavan M. Distinct assembly profiles of HLA-B molecules. J Immunol. 2014;192:4967\u201376.","journal-title":"J Immunol"},{"key":"3915_CR35","doi-asserted-by":"publisher","first-page":"e1007171","DOI":"10.1371\/journal.ppat.1007171","volume":"14","author":"J Geng","year":"2018","unstructured":"Geng J, Zaitouna AJ, Raghavan M. Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP). PLoS Pathog. 2018;14:e1007171.","journal-title":"PLoS Pathog"},{"key":"3915_CR36","doi-asserted-by":"crossref","unstructured":"Loonstra FC, de Ruiter LRJ, Koel-Simmelink MJA, Schoonheim MM, Strijbis EMM, Moraal B, Barkhof F, Uitdehaag BMJ, Teunissen C, Killestein J. Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023;10(2):e200078.","DOI":"10.1212\/NXI.0000000000200078"},{"key":"3915_CR37","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1093\/brain\/awab241","volume":"144","author":"S Bittner","year":"2021","unstructured":"Bittner S, Oh J, Havrdova EK, Tintore M, Zipp F. The potential of serum neurofilament as biomarker for multiple sclerosis. Brain. 2021;144:2954\u201363.","journal-title":"Brain"},{"key":"3915_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, Naegelin Y, Schadelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, et al. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017;81:857\u201370.","journal-title":"Ann Neurol"},{"key":"3915_CR39","doi-asserted-by":"publisher","first-page":"679199","DOI":"10.3389\/fnins.2021.679199","volume":"15","author":"F Verde","year":"2021","unstructured":"Verde F, Otto M, Silani V. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front Neurosci. 2021;15:679199.","journal-title":"Front Neurosci"},{"key":"3915_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","volume":"85","author":"F Puentes","year":"2014","unstructured":"Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G, Baker D, Amor S, Malaspina A. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2014;85:274\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3915_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/imm.12797","volume":"152","author":"F Puentes","year":"2017","unstructured":"Puentes F, van der Star BJ, Boomkamp SD, Kipp M, Boon L, Bosca I, Raffel J, Gnanapavan S, van der Valk P, Stephenson J, et al. Neurofilament light as an immune target for pathogenic antibodies. Immunology. 2017;152:580\u20138.","journal-title":"Immunology"},{"key":"3915_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/intimm\/dxp011","volume":"21","author":"R Huizinga","year":"2009","unstructured":"Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S. T-cell responses to neurofilament light protein are part of the normal immune repertoire. Int Immunol. 2009;21:433\u201341.","journal-title":"Int Immunol"},{"key":"3915_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2008.08.009","volume":"32","author":"R Huizinga","year":"2008","unstructured":"Huizinga R, Gerritsen W, Heijmans N, Amor S. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis. 2008;32:461\u201370.","journal-title":"Neurobiol Dis"},{"key":"3915_CR44","doi-asserted-by":"publisher","first-page":"100173","DOI":"10.1016\/j.jtauto.2022.100173","volume":"5","author":"BD Clarkson","year":"2022","unstructured":"Clarkson BD, Johnson RK, Bingel C, Lothaller C, Howe CL. Preservation of antigen-specific responses in cryopreserved CD4(+) and CD8(+) T cells expanded with IL-2 and IL-7. J Transl Autoimmun. 2022;5:100173.","journal-title":"J Transl Autoimmun"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03915-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:02:45Z","timestamp":1787745765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03915-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03915-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human samples were obtained from individuals providing written informed consent following protocols approved by the Mayo Clinic Institutional Review Board (IRB 17-004547; IRB 13-007298).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"285"}}